| HOME >> BIOLOGY >> TECHNOLOGY |
- Data demonstrates mortality reduction in endotoxemic patients through use
of combined diagnostic and therapeutic -
TORONTO, March 18 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI) today announced that new findings were presented showing a mortality reduction in endotoxemic patients through the combined use of Spectral's EAA(TM) Endotoxin Activity Assay, the only FDA cleared diagnostic for the measurement of endotoxin, and Toray Medical Company's Toraymyxin(TM) column, a blood purification device that absorbs endotoxin from the bloodstream. The findings will be presented in a symposium entitled "Measuring and targeting endotoxin in critical illness - from theory to practice" at the 28th International Symposium on Intensive Care and Emergency Medicine. The conference takes place in Brussels, Belgium from March 18-21, 2008 and focuses on developments in research, therapy, and management of critically ill patients.
"Our unique EAA(TM) diagnostic offers critical care physicians valuable information on the diagnosis of endotoxemia. Used in combination with Toray's therapy, EAA(TM) provides actionable data that has the potential to lead to a reduction in mortality as demonstrated by the findings presented at this important conference," said Dr. Paul Walker, President and CEO of Spectral Diagnostics. "Toraymyxin(TM) is highly effective in removing endotoxin from the bloodstream and our EAA(TM) product has the ability to identify patients who could benefit from the therapy and monitor its results. Together, the combined diagnostic and therapeutic has the potential to provide a more effective treatment for patients with endotoxemia."
Data compiled using Spectral's EAA(TM) will also be featured in several posters being presented at the conference. A manuscript describing the study of the combined use of EAA(TM) and Toraymyxin(TM) is currently being written and will be submitted for publication in 2008.
About Sp
'/>"/>
| SOURCE Spectral Diagnostics Inc. Copyright©2008 PR Newswire. All rights reserved |